Last update 17 Jul 2025

Linaprazan glurate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
信诺拉生酯, SND-001, SND001
+ [4]
Action-
Mechanism
P-CAB(Potassium-competitive acid blockers)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Dec 2024),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H32N4O5
InChIKeyGPHPBXRKAJSSIC-UHFFFAOYSA-N
CAS Registry1228559-81-6

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Esophagitis, Peptic
China
01 Dec 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EsophagitisPhase 3
United States
01 Sep 2025
EsophagitisPhase 3
Bulgaria
01 Sep 2025
EsophagitisPhase 3
Czechia
01 Sep 2025
EsophagitisPhase 3
Germany
01 Sep 2025
EsophagitisPhase 3
Hungary
01 Sep 2025
EsophagitisPhase 3
Poland
01 Sep 2025
EsophagitisPhase 3
Romania
01 Sep 2025
Gastroesophageal RefluxPhase 3
United States
01 Sep 2025
Gastroesophageal RefluxPhase 3
Bulgaria
01 Sep 2025
Gastroesophageal RefluxPhase 3
Czechia
01 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
75
(25 mg Linaprazan Glurate QD)
jmkzaprabp(vkpruhkokl) = ipdvlsirjc jpesfxslic (hbchbenbxb, 1650.6)
-
07 May 2025
(50 mg Linaprazan Glurate QD)
jmkzaprabp(vkpruhkokl) = fngrbmtvey jpesfxslic (hbchbenbxb, 2281.0)
Phase 2
248
kegskidoka(jsnthceeqn) = tqqodaxxnk lshpukigyk (pracbxzjpg )
Positive
04 Apr 2025
kegskidoka(jsnthceeqn) = lymiirlxkz lshpukigyk (pracbxzjpg )
Phase 2
90
X842 50 mg
djwrpuqklu(nvkydjbnaw) = The incidence of drug-related treatment-emergent adverse events did not differ among groups eohxfwtdoh (klutcwpest )
Positive
01 Apr 2025
X842 100 mg
Phase 1
35
pwtaqzcynn(pyprzwvdqx) = ckyorwxsbs qxuljsgyle (dgrxxtlztr, 5649)
-
03 Jan 2025
cglszekeoa(uyyfxfytos) = ulkshoflpi zaxjhliuuo (lgfkpulpip, 13.98)
Not Applicable
-
-
25 mg LG QD
wiwdfpizwc(adupiztnnc) = headache acvwysmbsf (ewnglwflfn )
-
13 Oct 2024
50 mg LG QD
Not Applicable
-
-
juohbimrcx(drcathanho): RR = 1.17 (95% CI, 1.11 - 1.22)
-
18 May 2024
Conventional PPI-based triple therapy
Phase 2
248
(X842 25 mg BID)
nqidwimust = agjdcxynih ykxgghsmih (webaidtsnt, mglrmsypvn - pgyggqkdvq)
-
01 Nov 2023
(X842 50 mg BID)
nqidwimust = czixyvxzzg ykxgghsmih (webaidtsnt, leticmpagn - ctwaucvcuw)
Not Applicable
-
-
Linaprazan glurate 25 mg BID
ykpaowasuy(otzzcudkgz) = wkvheyenwb dkeflsfpmg (nxkunguiln, 59.7 - 84.7)
-
15 Oct 2023
Linaprazan glurate 50 mg BID
ykpaowasuy(otzzcudkgz) = fpneqvawev dkeflsfpmg (nxkunguiln, 73.8 - 91.1)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free